The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

<b>Background:</b> Iron deficiency (ID) often coexists with heart failure (HF), and its prevalence increases with the severity of HF. Intravenous ferric carboxymaltose (FCM) has been associated with improvements in clinical outcomes, functional capacity, and quality of life (QoL) in pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Inderbir Padda, Sneha Annie Sebastian, Daniel Fabian, Yashendra Sethi, Gurpreet Johal
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Diseases
Subjects:
HFrEF
iron deficiency/iron deficiency anemia
ferric carboxymaltose
Online Access:https://www.mdpi.com/2079-9721/12/12/339
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items